Further analysis of the association of FABP7 expression with clinicopathologic characteristics of patients in the CCGA dataset showed that the level of FABP7 expression in patients with glioma correlated significantly patient age and tumor grade (p < 0.001, Figures 4(a) and 4(b)). This evidence concerns the gene FABP7 and central nervous system cancer.